The Joint Blog

JUNE 8, 2020

We continue to explore and report on new cannabis related university and certification programs that are popping up around the world to help meet the demand of employment for the sector. Interpret data to assess crop health and quality and adapt to growth conditions/pest management strategies. And much more!

Programs 32

Programs Research and Development Environment Packaging 32

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions. Image by Pfüderi from Pixabay.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

AUGUST 16, 2022

The New York State Cannabis Control Board (“CCB”) approved 15 Adult-Use Conditional Processor (“AUCP”) licenses during its public meeting today, adding a key link in the state’s budding adult-use cannabis supply chain. The application window for the adult-use cannabis conditional cultivator licenses closed on June 30, 2022.

Supply Chain 52

Supply Chain Conditions Cannabinoids Programs 52

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).

Consumption 109

Consumption Patients Research and Development Data 109

Cannabis Law Report

NOVEMBER 26, 2019

The FDA also published a revised Consumer Update detailing safety concerns about CBD products more broadly. This includes ongoing work to obtain and evaluate information to address outstanding questions related to the safety of CBD products, while maintaining the agency’s rigorous public health standards.

Safety 64

Safety Food CBD Oil 64

Cannabis Law Report

JUNE 16, 2021

This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol. This relationship enables us to initiate our clinical research program and marks an important step for Wake in Canada. ABOUT SANTÉ CANNABIS.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Canna Law Blog

DECEMBER 16, 2021

Psilocybin research license, which will allow the testing potency, conducting clinical investigations, researching efficacy and safety, and agricultural research. Expansive List of Qualifying Medical Conditions. The bill allocates $2 million for the grant program. Broad Justification.

Legislation 97

Legislation Treatment Therapy Conditions 97

MMJ Recs

MARCH 16, 2024

With increasing acceptance of medical marijuana as a legitimate treatment option for various health conditions, the industry has attracted significant attention from investors, entrepreneurs, and policymakers alike. Policy decisions related to taxation, zoning, and advertising also impact the industry’s operations and growth trajectory.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

Cannabis Law Report

OCTOBER 22, 2021

Cybin’s Research and Development team has completed 74 in-vitro and in-vivo evaluations of Cybin’s expanding portfolio of psychedelic compounds being designed for potential therapeutic applications for several mental health conditions.

Research and Development 52

Research and Development Safety Media Data 52

Cannabis Law Report

DECEMBER 26, 2021

In furtherance of its program, the Company filed US Provisional Patent Application No. “Entheon is proud to be making significant strides in its Entheon IQ™ program,” says Timothy Ko, Chief Executive Officer of Entheon. US Provisional Patent Filed. ” In Vivo Toxicity Assays Completed.

Research and Development 52

Research and Development Clinical Trials Treatment Packaging 52

Veriheal

AUGUST 3, 2021

This legislation provides important updates to our state’s medical [cannabis] program to ensure that patients have improved access to medication.”. That change would have marked a distinct expansion of Pennsylvania’s existing medical cannabis program, which only allows patients to procure their medicine from licensed dispensaries.

Legislation 98

Legislation Patients Supply Chain Dispensary 98

Cannabis Law Report

AUGUST 27, 2021

The Rules aim to promote social equity, safety and easy access to the cannabis marketplace while keeping local municipalities in control of how they want cannabis businesses to operate in their jurisdiction. New applicants may apply for either a conditional license or an annual license.

Cultivation 105

Cultivation Conditions Business Cannabis 105

Cannabis Law Report

SEPTEMBER 29, 2021

Medical students who register for the program will have access to eight hours of medical cannabis education, including the latest scientific research on the endocannabinoid system and the known effects of cannabis on the human body. TCI offers cannabis medical education in both English and Spanish. About Dr. Jan Roberts ?

Cannabinoids 52

Cannabinoids Education Patients Safety 52

The Cannigma

JUNE 15, 2021

However, the scientific data on CBG is nowhere near as developed as what we have on CBD. Families looking for the wonder plant started migrating to states with medical cannabis programs , becoming cannabis refugees, and their stories spread even further. . A multi-target panacea? Easy access. Kevin McGovern/Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

SpeedWeed

APRIL 29, 2021

OSCC provides cannabis products to compassion centers operating in Portsmouth, Providence and Warwick that serve more than 18,000 cannabis patients in Rhode Island’s medical program. increase from 2019, according to adult-use sales and production data from the state’s Cannabis Control Commission. Chamber of Commerce. billion overall.

Programs 52

Programs Seed-To-Sale Dispensary Cultivation 52

Cannabis Law Report

JULY 23, 2021

The bill includes several provisions for additional research to investigate the impact of legalization on public health, driving safety, and similar areas. of Health and Human Services to research the effects of cannabis on health conditions. Restorative Justice and Opportunity Programs. The Draft would also direct the Dep.

Research and Development 105

Research and Development DEA Programs State Laws 105

Cannabis Law Report

AUGUST 17, 2021

(Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced topline data from its open-label Phase 2 trial evaluating safety and efficacy of adjunctive oral ganaxolone treatment in 23 patients with seizures associated with tuberous sclerosis complex (TSC).

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

Cannabis Law Report

JULY 29, 2021

Tetra Bio-Pharma ( TSX: TBP ) ( OTCQB: TBPMF ) ( FRA:JAM1 ) is a leader in cannabinoid-derived drug discovery and development with a FDA and a Health Canada cleared clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. For more information visit: www.tetrabiopharma.com.

Research and Development 105

Research and Development Clinical Trials Events Cannabinoids 105

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. Additionally, there are misleading practices of “p-hacking” where researchers can manipulate data through different statistical tests (thanks to modern computer programs) looking for statistically significant findings.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Veriheal

AUGUST 31, 2020

Program between St. About Sinibaldo: Sinibaldo is an aspiring healthcare professional and a biomedical researcher in the Medical Scientist Training Program (M.D./Ph.D.) About Nishtha: Nishtha is pursuing neurology to become a physician-scientist in honor of her grandmother Nani who suffered from Alzheimer’s.

Research and Development 117

Research and Development Education Agriculture Patients 117

Veriheal

APRIL 11, 2022

He also emphasized the fact that medical cannabis programs are now legal in 37 states, as well as four out of five inhabited U.S. Because of these restrictive laws, the federal government enforces harsh rules that make it impossible for researchers to investigate the pros, cons, and safety of cannabis products. . territories.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

MMJ Recs

FEBRUARY 23, 2024

The foundational framework was laid with the establishment of the Michigan Medical Marijuana Program in 2008, signalling the state’s commitment to providing legal access to cannabis for qualified patients. Patients benefit from a broad spectrum of cannabis products addressing various medical conditions.

Marijuana 52

Marijuana Dispensary Research and Development Supply Chain 52

The Joint Blog

JUNE 12, 2019

” It continues; “The consensus of our survey sample is that MC appears to be relatively safe and effective for a variety of conditions and is being used by several routes of administration. Discussion: The data suggest overwhelming support for MC use in the hospice setting.

Research and Development 55

Research and Development Marijuana Education Patients 55

Cannabis Law Report

JUNE 7, 2021

NASDAQ: APDN) (Applied DNA or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, and its program development partner, Evvivax, S.R.L. 1.526 were reduced as expected and consistent with other CDC-reported data on vaccine-induced antibody neutralization against these variants 1. P1 (Brazil), and B.1.526

Clinical Trials 64

Clinical Trials Research and Development Therapy Supply Chain 64

The Joint Blog

APRIL 17, 2020

But as an older user-base with more complicated medical conditions continue to grow, it is important to understand how THC could adversely impact other co-administered medications. Medical cannabis is typically prescribed for patients with severe conditions including inflammatory conditions (e.g.,

Events 48

Events THC Chronic Pain Sleep 48

WeedAdvisor

SEPTEMBER 26, 2019

The patient count also includes 2,500 people who are enrolled in the state’s new opioid alternative pilot program. The following August, Pritzker permanently established the state’s medical marijuana program. He also expanded the list of qualifying conditions, opening the door for a broader group of patients.

Recreational 45

Recreational Patients Programs History 45

Canna Law Blog

NOVEMBER 26, 2019

The Hemp Rules (WAC 16-306-100) establish a hemp food certification program where hemp producers can voluntarily certify hemp grown for human consumption. In order to participate in the certification program, the producer must inform the WSDA of their desire to participate in the program and also must reimburse the WSDA the costs of testing.

Hemp 90

Hemp Food Compliance Compliance 90

Freedom Leaf

OCTOBER 15, 2018

Frontier Data predicts total sales of all CBD products in the U.S. On July 23, the World Health Organization’s Expert Committee on Drug Dependence stated that “no public health problems have been associated with CBD use” and that “CBD has been found to be generally well tolerated with a good safety profile.” will top $1.9 John’s wort.

DEA 51

DEA CBD Pharmaceutical Epilepsy 51

Greenspoon Marder Cannabis Law Group Blog

JULY 18, 2019

New Jersey recently responded to public demand to revise and expand its medical marijuana program to address issues such as supply scarcity, employment and hiring concerns, and geographic access problems. Ability to meet the overall health needs of qualified patients and safety of the public. authorizes home delivery to patients.

Law 40

Law Marijuana Education Safety 40

Cannabis Law Report

JUNE 1, 2021

“Our cost savings program is on track to deliver $150 – $200 million of savings within the next 18 months, and we remain committed to our path to profitability by the end of Fiscal 2022, while continuing to invest in an organization that is focused on insights, innovation and gaining momentum in the U.S. Net revenue.

Data 95

Data Vaping Supply Chain Business 95

Cannabis Law Report

JUNE 12, 2021

The Parker Psychedelic Research Chair is being funded by Calgary businessman Jim Parker, who donated $3 million to the Hotchkiss Brain Institute to establish the program. “The data was showing that psychedelics were providing benefits to people suffering from anxiety, depression, addiction and PTSD.

Therapy 105

Therapy Treatment Medicine Sleep 105

Cannabis Law Report

JULY 20, 2019

New Jersey recently responded to public demand to revise and expand its medical marijuana program to address issues such as supply scarcity, employment and hiring concerns, and geographic access problems. Ability to meet the overall health needs of qualified patients and safety of the public. authorizes home delivery to patients.

Law 40

Law Marijuana Education Cultivation 40

Cannabis Law Report

DECEMBER 16, 2021

Because recreational use of marijuana is increasing, especially as more states legalize it, the CDC believes it’s important for all workplaces to implement and address marijuana policies in their motor vehicle safety programs. This program gives New Mexico an edge in the growth of cannabis infrastructure. 1, 2022.

Cannabinoids 52

Cannabinoids Retail Policy Cultivation 52

Cannabis Law Report

JULY 30, 2019

In my estimation, the state’s overall program growth in Florida to date is impressive. The ASA highlights that it takes the FDA “an average of 9 years to approve any drug, but it only takes approximately two to four weeks for a medical cannabis patient with chronic pain to be approved by a state program.”

Marijuana 40

Marijuana Education Patients Research and Development 40

Cannabis Law Report

JANUARY 31, 2019

Greater acceptance of cannabis occurred in 1998 when Oregon, following California’s lead two years earlier, established a medical marijuana program. Oregon is not creating a new industry, it is converting an illegal cannabis production economy, and a loosely-regulated medical program, into a well-regulated legal market.

Legislation 61

Legislation Recreational Marijuana Policy 61

CannaMD

DECEMBER 9, 2020

The authors also list a range of additional conditions for which there are possible benefits of cannabis therapies, including opiate withdraw, dystonia, glaucoma, Alzheimer’s disease, anxiety and depression, anti-tumor effects, inflammatory bowel diseases, Parkinson’s disease, and sleep disorders. ACUTE EFFECTS OF MARIJUANA.

Marijuana 111

Marijuana Research and Development Consumption Vaping 111

Cannabis Law Report

APRIL 14, 2022

Accordingly, state pesticide programs have tried to provide some clarity to fill the gap left by EPA. Similar issues arise under state and federal employee safety and worker Right-to-Know laws, as employees must be educated on the chemicals present and proper handling and risk management procedures. million cars on the road.

Environment 52

Environment Agriculture Compliance Compliance 52